D2 Lymphadenectomy Superior to D1 Lymphadenectomy in Gastric Cancer Surgery;D2- doch besser als D1-Lymphadenektomie beim Magenkarzinom - Endgültige Resultate der holländischen Magenkarzinomstudie

Zentralblatt fur Chirurgie

Volumn 128, Issue 10, 2003, Pages 786-787

  Holscher A H ^a   Bollschweiler, E ^a   Metzger, R ^a   Monig S P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; FOLLOW UP; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; MORBIDITY; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK ASSESSMENT; SPLENECTOMY; STOMACH CARCINOMA; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE;

AGE FACTORS; AGED; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; PANCREATECTOMY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK; SPLENECTOMY; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0242612129     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44337     Document Type: Editorial

References (10)

1. Bollschweiler E, Mönig SP, Hölscher AH. Lymphknotenmetastasierung - Kann man sie vorhersagen? Onkologe 2001; 7: 604-609
2. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340: 908-914
3. Bonenkamp JJ, Songun I, Hermans J, Sasako M et al. Randomised comparison of morbidity after Dl and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748
4. Brennan MF. Lymph-Node Dissection for Gastric Cancer. N Engl J Med 1999; 340: 956-958
5. Cuschieri A, Weeden S, Fielding J et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 1996; 347: 995-999
6. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-1530
7. Hartgringk HH, van de Velde CJ. Final results of the Dutch D1 versus D2 gastric cancer trial. Book of abstract. International Gastric Cancer Congress, Rome, May 4-7, 2003
8. Junginger T. Lymphknotendissektion beim Magenkarzinom - Ende eines Glaubenskrieges? Dtsch Ärztebl 2001; 98: 101-102
9. Metzger R, Leichmann CG, Danenberg KD, Danenberg PV, Lenz HJ, Hayashi K et al. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol 1998; 16: 309-316
10. Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461